These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15450941

  • 21. A comet assay study reveals that aluminium induces DNA damage and inhibits the repair of radiation-induced lesions in human peripheral blood lymphocytes.
    Lankoff A, Banasik A, Duma A, Ochniak E, Lisowska H, Kuszewski T, Góźdź S, Wojcik A.
    Toxicol Lett; 2006 Feb 08; 161(1):27-36. PubMed ID: 16139969
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL, Shaddix SC, Brockman RW, Bennett LL.
    Cancer Res; 1982 Jun 08; 42(6):2260-4. PubMed ID: 7042080
    [Abstract] [Full Text] [Related]

  • 23. Interindividual differences in initial DNA repair capacity when evaluating H2O2-induced DNA damage in extended-term cultures of human lymphocytes using the comet assay.
    Andersson M, Stenqvist P, Hellman B.
    Cell Biol Toxicol; 2007 Nov 08; 23(6):401-11. PubMed ID: 17429744
    [Abstract] [Full Text] [Related]

  • 24. Differences in repair of DNA cross-links between lymphocytes and epithelial tumor cells from colon cancer patients measured in vitro with the comet assay.
    Herrera M, Dominguez G, Garcia JM, Peña C, Jimenez C, Silva J, Garcia V, Gomez I, Diaz R, Martin P, Bonilla F.
    Clin Cancer Res; 2009 Sep 01; 15(17):5466-72. PubMed ID: 19690199
    [Abstract] [Full Text] [Related]

  • 25. Genotoxicity of acrylamide in human lymphocytes.
    Blasiak J, Gloc E, Wozniak K, Czechowska A.
    Chem Biol Interact; 2004 Oct 15; 149(2-3):137-49. PubMed ID: 15501435
    [Abstract] [Full Text] [Related]

  • 26. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI, Plunkett W.
    Cancer Res; 1982 Jul 15; 42(7):2587-91. PubMed ID: 7083151
    [Abstract] [Full Text] [Related]

  • 27. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
    Tseng WC, Derse D, Cheng YC, Brockman RW, Bennett LL.
    Mol Pharmacol; 1982 Mar 15; 21(2):474-7. PubMed ID: 7048062
    [Abstract] [Full Text] [Related]

  • 28. A comparison of the in vitro genotoxicity of anticancer drugs idarubicin and mitoxantrone.
    Błasiak J, Gloc E, Warszawski M.
    Acta Biochim Pol; 2002 Mar 15; 49(1):145-55. PubMed ID: 12136935
    [Abstract] [Full Text] [Related]

  • 29. 1-beta-D-arabinofuranosylcytosine is cytotoxic in quiescent normal lymphocytes undergoing DNA excision repair.
    Yamauchi T, Kawai Y, Ueda T.
    Jpn J Cancer Res; 2002 Dec 15; 93(12):1334-41. PubMed ID: 12495473
    [Abstract] [Full Text] [Related]

  • 30. Protective action of vitamin C against DNA damage induced by selenium-cisplatin conjugate.
    Błasiak J, Kowalik J.
    Acta Biochim Pol; 2001 Dec 15; 48(1):233-40. PubMed ID: 11440175
    [Abstract] [Full Text] [Related]

  • 31. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
    Potter AJ, Rabinovitch PS.
    Mutat Res; 2005 May 02; 572(1-2):27-44. PubMed ID: 15790488
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay.
    Azqueta A, Pachón G, Cascante M, Creppy EE, López de Cerain A.
    Mutagenesis; 2005 May 02; 20(3):165-71. PubMed ID: 15817574
    [Abstract] [Full Text] [Related]

  • 34. The effect of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 1-beta-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cells.
    Loughlin S, Gandhi V, Plunkett W, Zwelling LA.
    Cancer Chemother Pharmacol; 1996 May 02; 38(3):261-8. PubMed ID: 8646801
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks.
    Yang LX, Douple EB, O'Hara JA, Wang HJ.
    Radiat Res; 1995 Sep 02; 143(3):302-8. PubMed ID: 7652168
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Use of novel plasmid constructs to demonstrate fludarabine triphosphate inhibition of nucleotide excision repair of a site-specific 1,2-d(GpG) intrastrand cisplatin adduct.
    Li MJ, Yang LY.
    Int J Oncol; 1999 Dec 02; 15(6):1177-83. PubMed ID: 10568825
    [Abstract] [Full Text] [Related]

  • 39. Modulation of cellular defense processes in human lymphocytes in vitro by a 1,4-dihydropyridine derivative.
    Ryabokon NI, Nikitchenko NV, Dalivelya OV, Goncharova RI, Duburs G, Konopacka M, Rzeszowska-Wolny J.
    Mutat Res; 2009 Dec 02; 679(1-2):33-8. PubMed ID: 19660575
    [Abstract] [Full Text] [Related]

  • 40. Analysis of cytotoxicities of platinum compounds.
    Goodisman J, Hagrman D, Tacka KA, Souid AK.
    Cancer Chemother Pharmacol; 2006 Jan 02; 57(2):257-67. PubMed ID: 16028101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.